Azafaros Revenue and Competitors
Estimated Revenue & Valuation
- Azafaros's estimated annual revenue is currently $3.1M per year.
- Azafaros's estimated revenue per employee is $155,000
Employee Data
- Azafaros has 20 Employees.
Azafaros's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Chief Medical Officer | Reveal Email/Phone |
Azafaros Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $81.4M | 375 | 40% | N/A | N/A |
#2 | $16.9M | 109 | 22% | N/A | N/A |
#3 | $156.1M | 120 | -70% | $145M | N/A |
#4 | $2.9M | 37 | -24% | $150M | N/A |
#5 | $1.3M | 17 | 0% | $459.5M | N/A |
#6 | $49.2M | 254 | 15% | $180.7M | N/A |
#7 | $7M | 45 | -2% | N/A | N/A |
#8 | $256.3M | 840 | 9% | $168.5M | N/A |
#9 | $4.2M | 27 | -7% | N/A | N/A |
#10 | $10.1M | 65 | 5% | N/A | N/A |
What Is Azafaros?
N/A
Total Funding
20
Number of Employees
$3.1M
Revenue (est)
N/A
Employee Growth %
N/A
Valuation
N/A
Accelerator
Azafaros News
2022-03-22 - Azafaros Announces FDA Grant of Orphan Drug Designation for AZ ...
AZ-3102, Azafaros' lead program, is currently in clinical development as a potential treatment for the rare lysosomal storage diseases GM1 and...
2022-02-22 - Azafaros Presents Positive Clinical and Preclinical Data Supporting ...
Azafaros also presented the design of PRONTO, a prospective longitudinal global study of neurological disease trajectory in children living with...
Other Companies in
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $2.9M | 20 | 0% | N/A |
#2 | $4.5M | 20 | -23% | N/A |
#3 | $2.9M | 20 | -20% | N/A |
#4 | $3.5M | 20 | 5% | N/A |
#5 | $2M | 20 | N/A | N/A |